About this newsletter
The ACP Advocate is an e-newsletter, edited by the College's Washington, DC governmental affairs division, created to provide you, our members, with succinct news about public policy issues affecting internal medicine and patient care. To learn more about ACP's Advocacy and to access the ACP Advocate archives, go to www.acponline.org/advocacy.
|
|
|
Welcome to The ACP Advocate.
In this week’s issue you’ll find continuing coverage of health care reform. We tell you about the comprehensive reform package that was released by the Senate Finance Committee Chairman, Senator Max Baucus. We also take a look at how liability reform is finally becoming part of the health care reform debate. Finally, you’ll find a new policy paper from the College that calls for reforms to the FDA to better enable them to monitor drug safety.
For more coverage of health care reform take a look at my blog, The ACP Advocate Blog by Bob Doherty. I encourage you to post your own comments and become part of the discussion taking place among members like you.
And, as always, please send your feedback and suggestions on this newsletter to: TheACPAdvocate@acponline.org.
Yours truly,
Bob Doherty
Senior Vice President
Governmental Affairs and Public Policy
American College of Physicians
|
In the news
» |
Baucus Bill Offers a Mixed Bag of Health-Reform Ideas |
|
Proposal mandates coverage, offers less-generous subsidies and fails to resolve the SGR formula debate
|
|
A heavily anticipated health-reform proposal released Sept. 16 by Sen. Max Baucus (D-Mont.), chairman of the Senate Finance Committee, contains many provisions that are consistent with policy established by the American College of Physicians. It also stray... » Click to read the full article
|
|
|
In focus
ACP Calls for Support for the FDA In a new policy paper released this week the College calls for reforms to improve the agency’s ability to approve and monitor new drugs. The complete paper can be found at the link above, and an in-depth look at the new policy can be found in the main section of this newsletter. |
|